Is telomere length associated with the cognitive response to a lifestyle intervention?

August 28, 2017, IOS Press
Dr. Shireen Sindi and colleagues have been examining the role of LTL in the trial. Credit: National Institute for Health and Welfare, Helsinki, Finland

A new study from the FINGER trial team shows that participants with shorter leukocyte telomere length (LTL) had more pronounced benefits on cognition following the multidomain lifestyle intervention.

"These findings are very promising, as individuals with shorter telomeres may represent an at-risk group", says Dr. Shireen Sindi, lead author of the study based at Karolinska Institute (Sweden) and Imperial College London (UK).

Telomeres are found at the end of chromosomes (which hold our DNA), protecting them from deteriorating or getting tangled up with neighboring chromosomes. Telomeres play an important role in the process of cell division.

The current study is the first to assess whether baseline LTL can modify the effects of a multidomain intervention on cognition among older adults who are at risk for decline. The results showed that the beneficial intervention effects on cognition were more pronounced among individuals with shorter baseline LTL, particularly for executive functioning. Consistent with previous studies, unhealthy lifestyle was associated with shorter baseline LTL among FINGER participants.

"This suggests to us that participants with shorter LTL had more room for lifestyle improvements when they entered the study", says Dr. Sindi. Adjusting for lifestyle however did not attenuate the observed findings.

Considering that shorter LTL has been associated with poor cognitive performance and dementia, "it is very encouraging that the multidomain lifestyle intervention was especially beneficial among individuals with higher risk" commented the authors.

In the absence of disease-modifying drugs for dementia and Alzheimer's disease, preventive initiatives have recently gained much attention as a promising intervention approach.

The Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER) (led by Professor Miia Kivipelto) is a comprehensive multidomain prevention trial including nutritional guidance, exercise training, computer-based cognitive training, and intensive management of vascular and metabolic risk factors. In this trial, 1,260 older adults (aged 60-77) were randomly allocated to the intervention or control groups (the latter receiving standard health advice). After 2 years, cognition scores (measured by the Neuropsychological Test Battery) were higher in the intervention group for total cognition as well as various cognitive domains (for the main results see Ngandu et al., 2015, The Lancet). This study was the first and largest of its kind, using a multidomain approach, with long follow-up duration and leading to a paradigm shift in the field of dementia prevention.

More recently, researchers in the FINGER team have been investigating the underlying biological mechanisms associated with the positive intervention effects. Dr. Shireen Sindi and colleagues have been examining the role of LTL in the trial.

When telomere length is shortened, their capacities to protect DNA are compromised. LTL is considered a biomarker of aging and aging-related diseases, representing cells' 'biological age' rather than 'chronological age'.

Previous studies have shown that various lifestyle and psychological factors are associated with shortened LTL, such as unhealthy diets, obesity, smoking, psychological stress, as well as psychiatric and health conditions, while healthy lifestyle factors such as physical exercise are associated with longer LTL.

LTL is also associated with cognition, and patients with Alzheimer's disease have shorter LTL. These same associations may be found among individuals with mild .

Despite the observational findings on lifestyle factors, cognitive impairment and LTL, few studies have investigated the role of LTL in the context of clinical trials, and none had focused on cognition as an outcome. This further highlights the value of the current findings from the FINGER trial.

The team is currently investigating the impact of the multidomain lifestyle intervention on LTL among FINGER participants, as this will provide insight on potential methods to enhance LTL.

Explore further: No link to cognition in diabetes prevention program study

More information: Shireen Sindi et al, Baseline Telomere Length and Effects of a Multidomain Lifestyle Intervention on Cognition: The FINGER Randomized Controlled Trial, Journal of Alzheimer's Disease (2017). DOI: 10.3233/JAD-170123

Related Stories

No link to cognition in diabetes prevention program study

May 22, 2017
(HealthDay)—For participants in the Diabetes Prevention Program (DPP) Outcomes Study (DPPOS), exposure to metformin or lifestyle intervention is not associated with cognition, according to research published online May ...

Healthy eating, exercise, and brain-training

March 11, 2015
A comprehensive programme providing older people at risk of dementia with healthy eating guidance, exercise, brain training, and management of metabolic and vascular risk factors appears to slow down cognitive decline, according ...

No cognitive benefit for long-term lifestyle intervention

January 12, 2017
(HealthDay)—For overweight and obese adults with diabetes mellitus, a long-term intensive lifestyle intervention does not offer cognitive benefits, according to a study published online Jan. 9 in the Journal of the American ...

Scientists use new data mining strategy to spot those at high Alzheimer's risk

July 28, 2017
The push to develop treatments for Alzheimer's disease has been a promising and disappointing endeavor over the past two decades, yielding a greater understanding of the disease yet still failing to generate successful new ...

Good nutrition, physical training and mental exercises can reverse physical frailty in the elderly: study

June 19, 2017
Physical frailty is common among the elderly and is strongly associated with cognitive impairment, dementia and adverse health outcomes such as disability, hospitalisation, and mortality. A four-year study conducted by researchers ...

Benefits of cognitive training in dementia patients unclear

February 22, 2017
Positive effects of cognitive training in healthy elderly people have been reported, but data regarding its effects in patients with dementia is unclear.

Recommended for you

Pregnancy history may be tied to Alzheimer's disease

July 18, 2018
A woman's history of pregnancy may affect her risk of Alzheimer's disease decades later, according to a study published in the July 18, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology. ...

Molecular tracer, seen with PET scan, shows concentrations of abnormal proteins

July 17, 2018
In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic ...

Yale-developed test for Alzheimer's disease directly measures synaptic loss

July 16, 2018
Yale researchers have tested a new method for directly measuring synaptic loss in individuals with Alzheimer's disease. The method, which uses PET imaging technology to scan for a specific protein in the brain linked to synapses, ...

New study highlights Alzheimer's herpes link, experts say

July 12, 2018
A new commentary by scientists at the Universities of Manchester and Edinburgh on a study by Taiwanese epidemiologists supports the viability of a potential way to reduce the risk of Alzheimer's disease.

Practice imperfect—repeated cognitive testing can obscure early signs of dementia

July 12, 2018
Alzheimer's disease (AD) is a progressive, neurodegenerative condition that often begins with mild cognitive impairment or MCI, making early and repeated assessments of cognitive change crucial to diagnosis and treatment.

The 'Big Bang' of Alzheimer's: Scientists ID genesis of disease, focus efforts on shape-shifting tau

July 10, 2018
Scientists have discovered a "Big Bang" of Alzheimer's disease – the precise point at which a healthy protein becomes toxic but has not yet formed deadly tangles in the brain.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.